Will Cardiovascular Outcomes Data on Newer Diabetes Drugs Bury the Older Agents?

被引：3

作者：

Flory, James ^{[1
]}

机构：

[1] Weill Cornell Med Coll, Dept Healthcare Policy & Res, 425 E 61st St,Ste 301, New York, NY 10021 USA

来源：

JAMA INTERNAL MEDICINE | 2017年 / 177卷 / 03期

关键词：

D O I：

10.1001/jamainternmed.2016.8284

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：301 / 302

页数：2

共 7 条

[1] 7. Approaches to Glycemic Treatment [J].

不详 .

DIABETES CARE, 2016, 39 :S52-S59

[2] Effects of Metformin Versus Glipizide on Cardiovascular Outcomes in Patients With Type 2 Diabetes and Coronary Artery Disease [J].

Hong, Jie ;

Zhang, Yife ;

Lai, Shenghan ;

Lv, Ankang ;

Su, Qing ;

Dong, Yan ;

Zhou, Zhiguang ;

Tang, Weili ;

Zhao, Jajun ;

Cui, Lianqun ;

Zou, Dajin ;

Wang, Dawang ;

Li, Hong ;

Liu, Chao ;

Wu, Guoting ;

Shen, Jie ;

Zhu, Dalong ;

Wang, Weiqing ;

Shen, Weifeng ;

Ning, Guang .

DIABETES CARE, 2013, 36 (05) :1304-1311

[3] Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes [J].

Marso, Steven P. ;

Daniels, Gilbert H. ;

Brown-Frandsen, Kirstine ;

Kristensen, Peter ;

Mann, Johannes F. E. ;

Nauck, Michael A. ;

Nissen, Steven E. ;

Pocock, Stuart ;

Poulter, Neil R. ;

Ravn, Lasse S. ;

Steinberg, William M. ;

Stockner, Mette ;

Zinman, Bernard ;

Bergenstal, Richard M. ;

Buse, John B. .

NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (04) :311-322

[4] Comparison of Clinical Outcomes and Adverse Events Associated With Glucose-Lowering Drugs in Patients With Type 2 Diabetes A Meta-analysis [J].

Palmer, Suetonia C. ;

Mavridis, Dimitris ;

Nicolucci, Antonio ;

Johnson, David W. ;

Tonelli, Marcello ;

Craig, Jonathan C. ;

Maggo, Jasjot ;

Gray, Vanessa ;

De Berardis, Giorgia ;

Ruospo, Marinella ;

Natale, Patrizia ;

Saglimbene, Valeria ;

Badve, Sunil V. ;

Cho, Yeoungjee ;

Nadeau-Fredette, Annie-Claire ;

Burke, Michael ;

Faruque, Labib ;

Lloyd, Anita ;

Ahmad, Nasreen ;

Liu, Yuanchen ;

Tiv, Sophanny ;

Wiebe, Natasha ;

Strippoli, Giovanni F. M. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 316 (03) :313-324

[5] Evaluating the Cardiovascular Safety of New Medications for Type 2 Diabetes: Time to Reassess? [J].

Smith, Robert J. ;

Goldfine, Allison B. ;

Hiatt, William R. .

DIABETES CARE, 2016, 39 (05) :738-742

[6] Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) [J].

Turner, RC ;

Holman, RR ;

Stratton, IM ;

Cull, CA ;

Matthews, DR ;

Manley, SE ;

Frighi, V ;

Wright, D ;

Neil, A ;

Kohner, E ;

McElroy, H ;

Fox, C ;

Hadden, D .

LANCET, 1998, 352 (9131) :854-865

[7] Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes [J].

Zinman, Bernard ;

Wanner, Christoph ;

Lachin, John M. ;

Fitchett, David ;

Bluhmki, Erich ;

Hantel, Stefan ;

Mattheus, Michaela ;

Devins, Theresa ;

Johansen, Odd Erik ;

Woerle, Hans J. ;

Broedl, Uli C. ;

Inzucchi, Silvio E. ;

Aizenberg, D. ;

Ulla, M. ;

Waitman, J. ;

De Loredo, L. ;

Farias, J. ;

Fideleff, H. ;

Lagrutta, M. ;

Maldonado, N. ;

Colombo, H. ;

Ferre Pacora, F. ;

Wasserman, A. ;

Maffei, L. ;

Lehman, R. ;

Selvanayagam, J. ;

d'Emden, M. ;

Fasching, P. ;

Paulweber, B. ;

Toplak, H. ;

Luger, A. ;

Drexel, H. ;

Prager, R. ;

Schnack, C. ;

Schernthaner, G. ;

Fliesser-Goerzer, E. ;

Kaser, S. ;

Scheen, A. ;

Van Gaal, L. ;

Hollanders, G. ;

Kockaerts, Y. ;

Capiau, L. ;

Chachati, A. ;

Persu, A. ;

Hermans, M. ;

Vantroyen, D. ;

Vercammen, C. ;

Van de Borne, P. ;

Mathieu, C. ;

Benhalima, K. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (22) :2117-2128

← 1 →